Michał Kurlapski

6PUBLICATIONS
47CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyHaematological tumoursAutoimmunityVeterinary epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 27, 2026
Radiation-Free Therapy for the Initial Treatment of Good Prognosis Early Non-Bulky Hodgkin Lymphoma, Defined by a Low Metabolic Tumor Volume and a Negative Interim PET After 2 Chemotherapy Cycles: The RAFTING Trial Protocol.

|Dec 26, 2025
PIM kinase inhibition attenuates pro-tumoral and immunosuppressive functions of macrophages in classic Hodgkin lymphoma.

Maciej Szydłowski, Ewa Kurtz, Filip Garbicz

|Aug 14, 2025
Metabolic Interactions in the Tumor Microenvironment of Classical Hodgkin Lymphoma: Implications for Targeted Therapy.

Michał Kurlapski, Alicja Braczko, Paweł Dubiela

|May 13, 2025
A comprehensive genetic study of classic Hodgkin lymphoma using circulating tumor DNA.

Maria Cristina Pirosa, Alessio Bruscaggin, Lodovico Terzi di Bergamo

|Apr 27, 2024
Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment-67 Patients Multicenter Analysis.

Grzegorz Charliński, Maximilian Steinhardt, Leo Rasche

|Aug 27, 2021
FDG-PET/CT for the Management of Post-Chemotherapy Residual Mass in Hodgkin lymphoma.

Andrea Gallamini, Michał Kurlapski, Jan Maciej Zaucha

Pageof 1

Frequent Collaborators

3 joint publications

Jan Maciej Zaucha

2 joint publications

Stephane Chauvie

1 joint publications

Grzegorz Charliński

1 joint publications

Maximilian Steinhardt